Serum metalloproteinase 9 levels increase after generalized tonic-clonic seizures

Agnieszka Cudna1, Anna Jopowicz1, Paweł Mierzejewski2

  • 12nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland.

Epilepsy Research
|November 26, 2016
PubMed

Insights

Matrix metalloproteinase 9 (MMP9) levels rise after seizures in epilepsy patients. MMP9 serum concentrations peaked 1-24 hours post-seizure, returning to normal by 72 hours.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Neurology

Background:

  • Matrix metalloproteinase 9 (MMP9) is an enzyme crucial for extracellular matrix degradation and blood-brain barrier integrity.
  • Elevated MMP9 levels are implicated in various neurological disorders, including epilepsy, suggesting a role in seizure pathogenesis.

Purpose of the Study:

  • To investigate the dynamic changes in serum MMP9 levels in epilepsy patients following acute generalized tonic-clonic seizures.

Main Methods:

  • Serum MMP9 concentrations were quantified using ELISA in 43 epilepsy patients.
  • Measurements were taken at 1-3, 24, and 72 hours post-seizure, with a single measurement for the control group.

Main Results:

  • Serum MMP9 levels were significantly elevated at 1-3 hours and 24 hours after a seizure compared to controls.
  • MMP9 concentrations returned to baseline levels by 72 hours post-seizure.

Conclusions:

  • The findings suggest MMP9 is released shortly before or during seizures.
  • Further research is warranted to elucidate the specific role and consequences of MMP9 elevation in epilepsy.

Related Concept Videos